Onderneming Pardes Biosciences, Inc.
Aandelen
PRDS
US69945Q1058
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 57
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
James Tananbaum
CEO | Chief Executive Officer | 59 | 01-01-21 |
Dennis Ryan
DFI | Director of Finance/CFO | 69 | 30-08-23 |
Chief Operating Officer | - | - | |
Ann D. Kwong
CTO | Chief Tech/Sci/R&D Officer | - | - |
Patrick O’Brien
IRC | Investor Relations Contact | - | - |
Dave Kuo
HRO | Human Resources Officer | - | - |
Sean P. Brusky
PRN | Corporate Officer/Principal | 47 | 01-05-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Tananbaum
CEO | Chief Executive Officer | 59 | 01-01-21 |
Dennis Ryan
DFI | Director of Finance/CFO | 69 | 30-08-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 63 331 613 | 36 906 514 ( 58,28 %) | 1 319 857 ( 2,084 %) | 58,28 % |
Bedrijfsgegevens
Pardes Biosciences, Inc.
2173 Salk Avenue Suite 250
92008, Carlsbad
+
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,61% | 42,59 mld. | |
+7,82% | 40,65 mld. | |
+48,66% | 40,57 mld. | |
-11,96% | 26,77 mld. | |
+8,01% | 24,81 mld. | |
-24,01% | 18,17 mld. | |
+28,57% | 12,05 mld. | |
-3,16% | 11,7 mld. | |
+7,47% | 11,1 mld. |